We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+16.99%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$691K
AUM Growth
+$78K
Cap. Flow
+$226M
Cap. Flow %
32,646.26%
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$61.5M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$54.4M
3
IUSG icon
iShares Core S&P US Growth ETF
IUSG
+$28.9M
4
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$16.7M
5
GLD icon
SPDR Gold Trust
GLD
+$9.38M

Top Sells

Rank Stock Value
1
FBT icon
First Trust NYSE Arca Biotechnology Index Fund
FBT
+$10.7M
2
GIS icon
General Mills
GIS
+$5.39M
3
MSFT icon
Microsoft
MSFT
+$3.32M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$3.24M
5
ENR icon
Energizer
ENR
+$2.86M

Sector Composition

Rank Sector Weight
1 Energy 28.66%
2 Technology 9.15%
3 Healthcare 7.9%
4 Financials 6.09%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHF icon
776
Brighthouse Financial
BHF
$3.63B
$2 ﹤0.01%
51
-4
-7% -$110
BOX icon
777
Box
BOX
$4.02B
$2 ﹤0.01%
100
– –
BURL icon
778
Burlington
BURL
$22B
$2 ﹤0.01%
10
– –
CBRE icon
779
CBRE Group
CBRE
$40.8B
$2 ﹤0.01%
48
– –
CDNS icon
780
Cadence Design Systems
CDNS
$90B
$2 ﹤0.01%
+24
New +$2.01K
CHRD icon
781
Chord Energy
CHRD
$7.79B
$2 ﹤0.01%
3,000
-1,000
-25% -$647
CLB icon
782
Core Laboratories
CLB
$538M
$2 ﹤0.01%
75
– –
CRWD icon
783
CrowdStrike
CRWD
$187B
$2 ﹤0.01%
+84
New +$1.68K
CVCO icon
784
Cavco Industries
CVCO
$4.39B
$2 ﹤0.01%
11
– –
DBX icon
785
Dropbox
DBX
$6.81B
$2 ﹤0.01%
+100
New +$2.11K
DEA
786
Easterly Government Properties
DEA
$1.18B
$2 ﹤0.01%
32
– –
DOCU
787
DocuSign
DOCU
$9.63B
$2 ﹤0.01%
+12
New +$1.51K
DORM icon
788
Dorman Products
DORM
$4.01B
$2 ﹤0.01%
24
– –
GNK icon
789
Genco Shipping & Trading
GNK
$1.17B
$2 ﹤0.01%
300
– –
HSBC icon
790
HSBC
HSBC
$355B
$2 ﹤0.01%
80
– –
HUM icon
791
Humana
HUM
$46.7B
$2 ﹤0.01%
5
– –
ICUI icon
792
ICU Medical
ICUI
$3.93B
$2 ﹤0.01%
9
– –
IT icon
793
Gartner
IT
$9.41B
$2 ﹤0.01%
20
– –
KNSL icon
794
Kinsale Capital Group
KNSL
$7.95B
$2 ﹤0.01%
+12
New +$1.6K
KWR icon
795
Quaker Houghton
KWR
$2.63B
$2 ﹤0.01%
12
– –
LAD icon
796
Lithia Motors
LAD
$7.78B
$2 ﹤0.01%
13
– –
LYG icon
797
Lloyds Banking Group
LYG
$87.4B
$2 ﹤0.01%
1,251
– –
MTB icon
798
M&T Bank
MTB
$36.2B
$2 ﹤0.01%
19
– –
NBIX icon
799
Neurocrine Biosciences
NBIX
$17.7B
$2 ﹤0.01%
18
– –
NCLH icon
800
Norwegian Cruise Line
NCLH
$8.89B
$2 ﹤0.01%
100
-400
-80% -$5.86K
30 31
32
33 34

Similar funds

4FG
4Thought Financial Group Syosset, New York $202M AUM 11.53% 1-Year Est. Return
BFA
Brendel Financial Advisors Hanover, New Hampshire $202M AUM 37.99% 1-Year Est. Return
PCMK
Paragon Capital Management (Kansas) Overland Park, Kansas $202M AUM 26.44% 1-Year Est. Return
CWM
CarsonAllaria Wealth Management Glen Carbon, Illinois $202M AUM 15.75% 1-Year Est. Return
AFWM
Arta Finance Wealth Management Mountain View, California $202M AUM
HWMO
Heritage Wealth Management (Ohio) Cincinnati, Ohio $202M AUM 23.85% 1-Year Est. Return
PCM
Pointe Capital Management Grosse Pointe Farms, Michigan $202M AUM 17.2% 1-Year Est. Return
BSA
Bull Street Advisors Savannah, Georgia $202M AUM 11.06% 1-Year Est. Return

tru Independence's Q2 2020 Portfolio in Review

As of Q2 2020, tru Independence held 960 positions worth $691K, up 13% from $613K the previous quarter. Its ten largest holdings account for 41% of the portfolio.

tru Independence deployed $226M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19.

By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.

  • tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19.
  • tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
  • tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
  • tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3K.
  • tru Independence's ten largest holdings make up 41% of its $691K portfolio in Q2 2020.
  • tru Independence opened 207 new positions and closed 53 in Q2 2020.
  • tru Independence's portfolio value rose 13% quarter-over-quarter to $691K.

Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.